You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科倫藥業(002422.SZ):擬分拆科倫博泰至香港聯交所上市
格隆匯 01-13 20:05

格隆匯1月13日丨科倫藥業(002422.SZ)公佈,公司擬將其控股子公司科倫博泰分拆至香港聯交所上市。此次分拆完成後,科倫藥業股權結構不會發生變化,且仍將保持對科倫博泰的控制權。

通過此次分拆,科倫博泰作為公司下屬生物創新藥研發、生產、上市及國際合作業務的主要平台將實現獨立上市,藉助香港資本市場融資擁抱國際資本市場,提高國際知名度,增強資金實力,為科倫博泰長遠發展夯實基礎。此次分拆有助於增強科倫博泰在國際市場的影響力,提高科倫博泰的綜合競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account